[1]
Juthong, S. and Eiamsa-ard, S. 2019. Roxithromycin as Anti-Inflammatory Drug Improves Clinical Outcomes in Adult Patients with Bronchiectasis: A Double- Blinded Randomized, Placebo-Controlled Pilot Clinical Trial. Journal of Health Science and Medical Research. 37, 3 (Jun. 2019), 229–236. DOI:https://doi.org/10.31584/jhsmr.201956.